RhumbLine Advisers
SRTA

RhumbLine Advisers’s Strata Critical Medical Inc SRTA Stock Holding History

RhumbLine Advisers’s Portfolio SRTA Stock Details SRTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$532K Buy
127,248
+1,019
+0.8% +$4.91K ﹤0.01% 2576
2025
Q4 		$607K Sell
126,229
-3,335
-3% -$16.1K ﹤0.01% 2556
2025
Q3 		$656K Sell
129,564
-5,155
-4% -$22.8K ﹤0.01% 2509
2025
Q2 		$543K Buy
134,719
+52,533
+64% +$171K ﹤0.01% 2639
2025
Q1 		$224K Sell
82,186
-58,593
-42% -$210K ﹤0.01% 3053
2024
Q4 		$598K Buy
140,779
+7,037
+5% +$26.8K ﹤0.01% 2556
2024
Q3 		$393K Buy
133,742
+47,210
+55% +$150K ﹤0.01% 2870
2024
Q2 		$301K Sell
86,532
-2,599
-3% -$8.67K ﹤0.01% 3004
2024
Q1 		$254K Sell
89,131
-6,761
-7% -$20.9K ﹤0.01% 3057
2023
Q4 		$338K Buy
95,892
+10,065
+12% +$28.9K ﹤0.01% 2906
2023
Q3 		$222K Sell
85,827
-7,047
-8% -$24.8K ﹤0.01% 3099
2023
Q2 		$366K Buy
92,874
+8,832
+11% +$28K ﹤0.01% 2887
2023
Q1 		$284K Buy
84,042
+587
+0.7% +$2.39K ﹤0.01% 2632
2022
Q4 		$299K Buy
83,455
+1,992
+2% +$8.51K ﹤0.01% 2679
2022
Q3 		$328K Sell
81,463
-3,302
-4% -$17K ﹤0.01% 2690
2022
Q2 		$378K Buy
+84,765
New +$612K ﹤0.01% 2631

Other funds holding SRTA

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
TP
Third Point New York $2.08B AUM 27.04% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
NRCM
Northern Right Capital Management Darien, Connecticut $281M AUM 56.22% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
PLC
Pillsbury Lake Capital San Francisco, California $221M AUM
First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

RhumbLine Advisers's SRTA Position: Q1 2026 in Review

RhumbLine Advisers increased its Strata Critical Medical Inc (SRTA) stake by 0.81% in Q1 2026, buying an estimated $4.91K and bringing the position to 127,248 shares worth $532K. The position accounts for ﹤0.01% of the portfolio, ranked #2576.

RhumbLine Advisers first reported a position in SRTA in Q2 2022 and has held it in 16 quarters since. The position peaked at $656K in Q3 2025. 125 funds tracked by Wall St. Rank hold SRTA as of Q1 2026.

  • RhumbLine Advisers held 127,248 shares of Strata Critical Medical Inc worth $532K as of Q1 2026.
  • RhumbLine Advisers bought 1,019 Strata Critical Medical Inc shares in Q1 2026, an estimated $4.91K.
  • Strata Critical Medical Inc made up ﹤0.01% of RhumbLine Advisers's portfolio in Q1 2026, its #2576 holding.
  • RhumbLine Advisers first reported a position in Strata Critical Medical Inc in Q2 2022 and has held it in 16 quarters since.
  • RhumbLine Advisers's Strata Critical Medical Inc position peaked at $656K in Q3 2025.
  • 125 funds tracked by Wall St. Rank held Strata Critical Medical Inc as of Q1 2026.

Based on RhumbLine Advisers's 13F filing for Q1 2026, filed 12 May 2026.